| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/14/2008 | US20080038819 Micro Rna Inhibiting the Expression of Wt1 Gene and Utilization of the Same |
| 02/14/2008 | US20080038772 Composition, method and kit for reducing background staining |
| 02/14/2008 | US20080038745 Nucleotide analogs with six-membered rings |
| 02/14/2008 | US20080038403 Weight management system for obese animals |
| 02/14/2008 | US20080038391 Stable and bioavailable compositions of isomers of carotenoids for skin and hair |
| 02/14/2008 | US20080038390 Alkaloid compounds and their use as anti-malarial drugs |
| 02/14/2008 | US20080038389 Appetite-Suppressing Compositions And Methods |
| 02/14/2008 | US20080038387 Therapy of estrogen-associated disorders |
| 02/14/2008 | US20080038386 Use of a liquid cooling sensate to provide a pungent, warming or tingling sensate composition |
| 02/14/2008 | US20080038382 Extracts of Scutellaria for the Treatment of Sars |
| 02/14/2008 | US20080038381 Application of green tea extract and its major components in keloid scar therapy |
| 02/14/2008 | US20080038374 New Use |
| 02/14/2008 | US20080038371 Solid Lipid Nanoparticles comprising a hydrophilic platinum complex comprising anionic ligands and ligands containing amino groups such as trans-{bis[trans(diammine)(chloro)platinum (II) ( mu -1,6-hexanediamine)]}diammineplatinum tetranitrate salt |
| 02/14/2008 | US20080038370 Composition and method for treating the effects of diseases and maladies of the upper digestive tract |
| 02/14/2008 | US20080038363 Aerosol delivery system and uses thereof |
| 02/14/2008 | US20080038361 Water-Soluble Nanoparticles Stabilized with Multi-Functional Group Ligands and Method of Preparation Thereof |
| 02/14/2008 | US20080038358 Dry powder formulations of antihistamine for nasal administration |
| 02/14/2008 | US20080038357 Inhalation Powder Containing the CGRP antagonist BIBN4096 and Process for the Preparation Thereof |
| 02/14/2008 | US20080038355 Bioadhesive dosage form of steroids |
| 02/14/2008 | US20080038353 Polymer Based Nano-Carriers For The Solubilization And Delivery Of Hydrophobic Drugs |
| 02/14/2008 | US20080038350 Low-dosage peroral medication for contraception containing crystalline dienogest and ethinyl estradiol |
| 02/14/2008 | US20080038348 Modified release formulations of a bupropion salt |
| 02/14/2008 | US20080038347 Extended release tablet formulations of flibanserin and method for manufacturing the same |
| 02/14/2008 | US20080038346 Extended release tablet formulations of flibanserin and method for manufacturing the same |
| 02/14/2008 | US20080038345 Microparticles having osmotic subcoat; extended release tablets; shelf life; hydrobromide form |
| 02/14/2008 | US20080038344 Solid Pharmaceutical Preparation |
| 02/14/2008 | US20080038343 Pharmaceutical composition containing a tetrahydrofolic acid |
| 02/14/2008 | US20080038342 Stable Pharmaceutical Composition Comprising an Ace Inhibitor |
| 02/14/2008 | US20080038341 Direct Compression Formulation And Process |
| 02/14/2008 | US20080038338 Tetracycline Package Formulations |
| 02/14/2008 | US20080038336 Solid pharmaceutical composition containing a combination of an intestinal motility regulating agent and an antiflatulent |
| 02/14/2008 | US20080038335 Method, formulation, and use thereof for improved oral absorption of pharmaceuticals or nutrients |
| 02/14/2008 | US20080038333 Formulations For Poorly Soluble Drugs |
| 02/14/2008 | US20080038332 Stable pharmaceutical formulation comprising atorvastatin calcium |
| 02/14/2008 | US20080038331 Enantiomerically pure S-etifoxine, pharmaceutical compositions thereof and methods of their use |
| 02/14/2008 | US20080038330 Preparations for the application of anti-inflammatory, especially antiseptic agents and/or agents promoting the healing of wounds of the lower respiratory tract |
| 02/14/2008 | US20080038328 Pasting Preparation |
| 02/14/2008 | US20080038323 Methods for Improving Liver Clearance of Xenobiotic Substances in an Animal |
| 02/14/2008 | US20080038321 Prophylactic/therapeutic compositions for liver diseases |
| 02/14/2008 | US20080038318 Composition; Use Of A Composition And A Method For Treating Obesity |
| 02/14/2008 | US20080038316 Conveniently implantable sustained release drug compositions |
| 02/14/2008 | US20080038313 Systems, methods, and compositions for mixing and applying lyophilized biomaterials |
| 02/14/2008 | US20080038312 Insertable or implantable medical devices suitable for gene therapy regimens |
| 02/14/2008 | US20080038310 Coating comprising an elastin-based copolymer |
| 02/14/2008 | US20080038309 Use of polypeptides obtained through systematic mutations of single amino acids of human and non-human Box-A of HMGB1 to prevent and/or antagonize pathologies induced by HMGB1 |
| 02/14/2008 | US20080038308 Silencing RNA molecules and their use in bone formation |
| 02/14/2008 | US20080038307 Biocompatible Coating, Method, and Use of Medical Surfaces |
| 02/14/2008 | US20080038306 Fluidic Tissue Augmentation Compositions and Methods |
| 02/14/2008 | US20080038300 Self-Adhesive Skin Patch and Combination Set for Cosmetic Skin Care |
| 02/14/2008 | US20080038297 Genetic adjuvants for viral vaccines |
| 02/14/2008 | US20080038296 Targeted delivery of drugs, therapeutic nucleic acids and functional nucleic acids to mammalian cells via intact killed bacterial cells |
| 02/14/2008 | US20080038289 Antitumor Agent |
| 02/14/2008 | US20080038284 Human Immunodeficiency Virus Vaccine |
| 02/14/2008 | US20080038281 Model membrane systems |
| 02/14/2008 | US20080038280 A32 Monoclonal Antibody Fusion Proteins For Use As Hiv Inhibitors And Vaccines |
| 02/14/2008 | US20080038278 GPAT3 encodes a mammalian, microsomal acyl-coa:glycerol 3- phosphate acyltransferase |
| 02/14/2008 | US20080038277 Dna Pkinase Inhibitors For Treating Cancer And Diabetes |
| 02/14/2008 | US20080038276 carbamimidoyl benzylamide derivatives; preventing and treating the formation of thrombin during or after a PK dependent disease or condition after fibrinolysis treatment |
| 02/14/2008 | US20080038268 Streptococcus Pyogenes Antigens |
| 02/14/2008 | US20080038266 Antibody or antigen binding fragment that binds acetyl-coA-acetyltransferase of Clostridium difficile |
| 02/14/2008 | US20080038263 Methods using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of mantle cell lymphomas |
| 02/14/2008 | US20080038255 Splice Variant of Unc5h2 |
| 02/14/2008 | US20080038251 MN/CA IX and MAPK inhibition |
| 02/14/2008 | US20080038250 Profilin and related immunomodulatory ligands |
| 02/14/2008 | US20080038248 Proteins Ligands For Nkg2d And Ul16 Receptors And Uses Thereof |
| 02/14/2008 | US20080038247 Diagnostics and Therapeutics for Diseases Associated With G-Protein-Coupled Receptor Gpr39 (Gpr39) |
| 02/14/2008 | US20080038245 Methods of modulating angiogenesis |
| 02/14/2008 | US20080038244 Materials and Methods Relating to Cell Cycle Control |
| 02/14/2008 | US20080038242 sodium-dependent nucleoside transporter 2 inhibitors; for diseases associated with abnormal plasma uric acid levels such as gout, hyperuricemia, urinary lithiasis, hyperuriciemic nephropathy, and acute uric acid nephropathy |
| 02/14/2008 | US20080038228 Method |
| 02/14/2008 | US20080038227 Animal model of neurodegenerative diseases, the procedure for producing the model and applications thereof |
| 02/14/2008 | US20080038225 Triazolyl acyclic hepatitis c serine protease inhibitors |
| 02/14/2008 | US20080038224 Modified interferon-beta (IFN-beta) polypeptides |
| 02/14/2008 | US20080038221 Method For Producing Protein Adsorption-Preventing Ocular Lens Material |
| 02/14/2008 | US20080038220 Testosterone Gels Comprising Propylene Glycol as Penetration Enhancer |
| 02/14/2008 | US20080038219 Novel Composition for a Topical Skin Treatment Base and Medicated Applications Thereof |
| 02/14/2008 | US20080038209 Nicotine Delivery Product and Method for Producing It |
| 02/14/2008 | US20080038207 Method and device for decreasing contamination |
| 02/14/2008 | US20080038205 Novel dermatophagoides proteins |
| 02/14/2008 | US20080038200 Model for neurodegenerative diseases involving amyloid accumulation |
| 02/14/2008 | US20080038199 Methods Related to the Treatment of Neurodegenerative and Inflammatory Conditions |
| 02/14/2008 | US20080038195 radiolabeling; neurodegenerative diseases |
| 02/14/2008 | US20080035155 Topical Antiviral Formulations |
| 02/14/2008 | US20080035141 Aerosolized therapy kit |
| 02/14/2008 | DE202007016505U1 Re-Vital Kapseln für Männer Re-Vital Capsules for Men |
| 02/14/2008 | DE202007001170U1 Zusammensetzung, insbesondere für das Blockieren von Kathetern Composition, in particular for blocking catheters |
| 02/14/2008 | DE102006037920A1 Spezielle Carbonylbisimino-Verbindungen zur Behandlung von Immunerkrankungen Carbonylbisimino specific compounds for the treatment of immune diseases |
| 02/14/2008 | DE102006037478A1 2-(Heterocyclylbenzyl)-pyridazinonderivate 2- (Heterocyclylbenzyl) -pyridazinone derivatives |
| 02/14/2008 | DE102006037298A1 Pharmazeutische Zusammensetzung, insbesondere Antazidum A pharmaceutical composition, in particular antacid |
| 02/14/2008 | CA2836006A1 Use of 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for the treatment of mantle cell lymphomas |
| 02/14/2008 | CA2675243A1 Milnacipran for the treatment of fatigue associated with fibromyalgia syndrome |
| 02/14/2008 | CA2666193A1 Arylaminoaryl-alkyl-substituted imidazolidine-2,4-diones, process for preparing them, medicaments comprising these compounds, and their use |
| 02/14/2008 | CA2660695A1 Compositions comprising extracts of salix and andrographis paniculata useful in the treatment of chronic inflammatory conditions |
| 02/14/2008 | CA2660658A1 Osmium compounds |
| 02/14/2008 | CA2660636A1 Nucleosides, drugs containing these and use thereof |
| 02/14/2008 | CA2660538A1 Nitrate esters of piperidines |
| 02/14/2008 | CA2660523A1 Methods and means for treating dna repeat instability associated genetic disorders |
| 02/14/2008 | CA2660427A1 Pharmaceutical composition |
| 02/14/2008 | CA2660424A1 Sulfonamide compound or salt thereof |
| 02/14/2008 | CA2660421A1 1h-quinolin-4-one compounds, with affinity for the gaba receptor, processes, uses and compositions |